Archive

Colombian ivermectin study – how protocol violations influenced results

Written by | 26 Mar 2021

The results of the recent controlled trial of ivermectin for covid-19 in Colombia suggest that both ivermectin and control groups received ivermectin, according to Dr David Scheim. https://www.youtube.com/watch?v=T67szXgTqWw&ab_channel=MedicalUpdateOnline […]

Protocol violations in Colombian ivermectin study compromise results

Written by | 25 Mar 2021

Dr David Scheim explains how multiple protocol violations and widespread use of over-the-counter ivermectin could have compromised the results of a recent controlled trial of ivermectin for covid-19 […]

Ivermectin in Peru – results that save lives

Written by | 24 Mar 2021

Dr David Scheim explains how the original analysis factored out confounders and showed a 74% reduction in deaths at 30 days as a result of intensive ivermectin distribution. […]

Analysis confirms 14 fold reduction in deaths with Ivermectin treatment in Peru

Written by | 23 Mar 2021

Further analysis of results from Peru has now shown that systematic treatment of the population for covid-19 with ivermectin resulted in a 14-fold reduction in excess deaths. IMI interviewed Dr […]

COVID-19 nasal swab test may not be best for those who’ve had sinus surgery

Written by | 1 Mar 2021

People who have had major sinus surgery should consult their ENT doctor before undergoing COVID-19 swab testing, new research indicates. Likewise, those performing swab testing should ask whether […]

Ivermectin mass treatment in perspective

Written by | 17 Feb 2021

Ivermectin is a good treatment to use interim to and complementary to immunisations, according to Dr David Scheim, one of the authors of a study of mass treatment for covid-19 […]

Ivermectin dosing and distribution for mass treatment

Written by | 16 Feb 2021

Dr David Scheim, one of the authors of a recent study in Peru, describes the doses of ivermectin that were used and the strategies for effective mass distribution. https://www.youtube.com/watch?v=MSkKU18VlNo […]

Results of using ivermectin for mass treatment

Written by | 15 Feb 2021

Mature, real world data on systematic mass treatment of covid-19 with ivermectin show a sharp fall in excess deaths. IMI interviewed Dr David Scheim, one of the authors […]

The impact of covid-19 on lung cancer care

Written by | 4 Feb 2021

Delayed diagnoses and more patients with advanced cancers were consequences of the coronavirus pandemic, according to Dr Erin Schenk, Assistant Professor, Thoracic Oncology, University of Colorado. The coronavirus […]

Ivermectin gathers pace in Europe

Written by | 31 Jan 2021

During the past week Slovakia became the first European country to give formal approval for the use of ivermectin for both prophylaxis and treatment of covid-19 patients. Ivermectin […]

Ivermectin meta-analysis – the implications

Written by | 27 Jan 2021

Dr Tess Lawrie, Director of the Evidence-based Medicine Consultancy Ltd, describes the implications of her recently-published meta-analysis of ivermectin trials for covid-19. https://www.youtube.com/watch?v=fh5iGkX8Vp4 Dr Lawrie is now trying to make […]

Ivermectin meta-analysis – the findings

Written by | 26 Jan 2021

Dr Tess Lawrie, Director of the Evidence-based Medicine Consultancy Ltd, describes the key findings from her recently-published meta-analysis of ivermectin trials for covid-19. https://www.youtube.com/watch?v=WTTqKSYHOM8 The first finding was that […]

Newsletter Icon

Sign up to our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Sign Up

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.